Millennium Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Millennium Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,504	Closed	-$21K	–	4442
2018 Q3	$21K	Sell	12,504 -101,071	-89%	-$181K	﹤0.01%	3830
2018 Q2	$198K	Sell	113,575 -390,808	-77%	-$676K	﹤0.01%	3561
2018 Q1	$923K	Buy	504,383 +485,558	+2,579%	+$1.03M	﹤0.01%	2730
2017 Q4	$42K	Buy	+18,825	New	+$46.8K	﹤0.01%	3728
2017 Q3	–	Sell	-3,064,748	Closed	-$13.6M	–	4085
2017 Q2	$13.6M	Sell	3,064,748 -191,319	-6%	-$789K	0.02%	882
2017 Q1	$15.2M	Buy	3,256,067 +1,394,118	+75%	+$8.08M	0.03%	801
2016 Q4	$11.3M	Buy	1,861,949 +1,828,771	+5,512%	+$9.56M	0.02%	853
2016 Q3	$183K	Sell	33,178 -966,571	-97%	-$4.53M	﹤0.01%	3003
2016 Q2	$3.8M	Sell	999,749 -779,718	-44%	-$2.64M	0.01%	1426
2016 Q1	$4.91M	Sell	1,779,467 -961,319	-35%	-$3.48M	0.01%	1260
2015 Q4	$15.5M	Buy	2,740,786 +50,927	+2%	+$310K	0.03%	677
2015 Q3	$14.3M	Buy	2,689,859 +377,257	+16%	+$2.92M	0.03%	735
2015 Q2	$19.2M	Buy	2,312,602 +2,141,766	+1,254%	+$10.4M	0.04%	649
2015 Q1	$789K	Buy	170,836 +49,003	+40%	+$159K	﹤0.01%	2456
2014 Q4	$372K	Buy	121,833 +35,083	+40%	+$104K	﹤0.01%	3208
2014 Q3	$242K	Sell	86,750 -243,940	-74%	-$885K	﹤0.01%	3263
2014 Q2	$1.35M	Buy	330,690 +246,685	+294%	+$1.05M	﹤0.01%	2016
2014 Q1	$446K	Sell	84,005 -71,530	-46%	-$401K	﹤0.01%	2691
2013 Q4	$864K	Buy	155,535 +143,063	+1,147%	+$617K	﹤0.01%	2374
2013 Q3	$56K	Sell	12,472 -62,844	-83%	-$282K	﹤0.01%	3219
2013 Q2	$321K	Buy	+75,316	New	+$378K	﹤0.01%	2551

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Millennium Management's SGYP Position: Q4 2018 in Review

Millennium Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 12,504 shares — an estimated $21K sold.

Millennium Management first reported a position in SGYP in Q2 2013 and held it in 21 quarters. The position peaked at $19.2M in Q2 2015. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Millennium Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Millennium Management sold 12,504 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $21K.
Millennium Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 21 quarters.
Millennium Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $19.2M in Q2 2015.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.